1Colombel M, Soloway M, Akaza H, et al. Epidemiology, staging, grading, and risk stratification of bladder cancer[ J]. Eur Urol Suppl, 2008, 7(10): 618-626.
2Vogelzang N J, Stadler W M. Kidney cancer[J]. Lancet, 1998, 352 (9141) : 1691 - 1696.
3Botteman M F, Pashos C L, Redaelli A, et al. The health economics of bladder cancer: a comprehensive review of the published literature [ J ]. Pharmacoeconomics, 2003, 21 ( 18 ) : 1315 - 1330.
4Schoffski P, Dumez H, Clement P, et al. Emerging role of tyrosine kinase inhibitors in the treatment of advanced renal cell cancer: a review [J]. Ann Oncol, 2006, 17(8): 1185 - 1196.
5Dahut W L, Scripture C, Posadas E, et al. A phase Ⅱ clinical trial of sorafenib in androgen -independent prostate cancer[ J]. Clin Cancer Res, 2008, 14(1): 209 - 214.
6Stenzl A, Hennenlotter J, Schilling D. Can we still afford bladder cancer? [J]. Curr Opin Urol, 2008, 18(5) : 488 -492.
7Grasso M. Bladder cancer: a major public health issue[ J]. Eur Urol Suppl, 2008, 7(7):510-515.
8Mozer P, Troccaz J, Stoianovici D. Urologic robots and future directions[J]. Curr Opin Urol, 2009, 19(1):114-119.
3Marks L S, DiPaola R S, Nelson P, et al. PC-SPES: herbal formulation for prostate cancer [J]. Urology, 2003, 61(6): 1292-1300.
4Ikezoe T, Chen S S, Tong X J, et al. Oridonin induces growth inhibition and apoptosis of a variety of human cancer cells[J]. Int J Oncol, 2003, 23: 1187-1193.
5Huschtscha L I, Jeitner T M, Andersson C E, et al. Identification of apoptotic and necrotic human leukemic cells by flow cytometry[J].Exp Cells Res, 1994, 212(1):161- 165.
6Abdullaev-Jafarova F, Caballero-Ortega H, Riveron-Negrete L,et al. In vitro evaluation of the chemopreventive potential of saffron[ J]. Rev Invest Clin, 2002, 54(5) : 430 -436.
7He S Y, Qian Z Y, Tang F T, et al. Effect of crocin on experimental atherosclerosis in quails and its mechanisms [ J]. Life Sci, 2005, 77 (8) : 907 -921.
8Garcia-Olmo D C, Riese H H, Escribano J, et al. Effects of long-term treatment of colon adenocarcinoma with crocin, a carotenoid from saffron (Crocus sativus L. ) : an experimental study in the rat[J]. Nutr Cancer, 1999, 35(2) :120 - 126.
9Escribano J, Alonso G L, Coca-Prados M, et al. Crocin, safranal and picrocrocin from saffron ( Crocus sativus L. ) inhibit the growth of human cancer cells in vitro[ J ]. Cancer Lett, 1996, 100( 1 - 2) : 23 - 30.
10Campbell K L, McTiernan A, Li S S, et al. Effect of a 12-month exercise intervention on the apoptotic regulating proteins Bax and Bcl-2 in colon crypts: a randomized controlled trial[ J ]. Cancer Epidemiol Biomarkers Prey, 2007,16(9) :1767 - 1774.
3Pruszak J, Ludwig W, Blak A, et al. CD15, CD24, and CD29 define a surface biomarker code for neural lineage differentiation of stem cells [Jl. Stem Cells, 2009, 27(12): 2928-2940.
4Roberts Z J, Ching L M, Vogel S N. IFN-beta-dependent inhibition of tumor growth by the vascular disrupting agent 5, 6-dimethylxanthe- none-d-acetic acid (DMXAA) [ J]. J Interferon Cytokine Res, 2008, 28(3) : 133 -139.
5Wang G X, Zhan Y A, Hu H L, et al. Mesenchymal Stem Cells Modified to Express Interferon- Inhibit the Growth of Prostate Cancer in a Mouse Model[J]. J Int Med Res, 2012, 40(1) : 317 -327.
6Dvorakova J, Hruba A, Velebny V, et al. Isolation and characteriza- tion of mesenchymal stem cell population entrapped in bone marrow collection sets[J]. Cell Biol Int, 2008, 32(9) : 1116 -1125.
